glp 1 kidney Potential renoprotective effects of GLP1 receptor agonists. The GLP-1s lower BMI, preserve kidney

A product specifically formulated to include both actives in a stable, pH-balanced system with appropriate attention to chelation, emulsion type, and antioxidant systems is a meaningfully different situation from ad-hoc layering of two separate products

Currently, no long-term human studies exist , but BPC-157 has shown no signs of organ damage or hormonal suppression in months-long rodent studies

Physiology 21 , 307315 (2006)

Williams, J

Nooms Proactive Health Microdose GLP-1Rx is open to adults with a BMI of 21 or higher, a group the brand says represents the vast majority of US adults. Getting started still involves medical oversight